Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
- PMID: 20068560
- DOI: 10.1038/ajg.2009.727
Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
Erratum in
- Am J Gastroenterol. 2010 Mar;105(3):500
Abstract
Guidelines for clinical practice are aimed to indicate preferred approaches to medical problems as established by scientifically valid research. Double-blind placebo controlled studies are preferable, but compassionate-use reports and expert review articles are used in a thorough review of the literature conducted through Medline with the National Library of Medicine. When only data that will not withstand objective scrutiny are available, a recommendation is identified as a consensus of experts. Guidelines are applicable to all physicians who address the subject regardless of specialty training or interests and are aimed to indicate the preferable but not necessarily the only acceptable approach to a specific problem. Guidelines are intended to be flexible and must be distinguished from standards of care, which are inflexible and rarely violated. Given the wide range of specifics in any health-care problem, the physician must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the board of trustees. Each has been intensely reviewed and revised by the Committee, other experts in the field, physicians who will use them, and specialists in the science of decision analysis. The recommendations of each guideline are therefore considered valid at the time of composition based on the data available. New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at publication to assure continued validity. The recommendations made are based on the level of evidence found. Grade A recommendations imply that there is consistent level 1 evidence (randomized controlled trials), grade B indicates that the evidence would be level 2 or 3, which are cohort studies or case-control studies. Grade C recommendations are based on level 4 studies, meaning case series or poor-quality cohort studies, and grade D recommendations are based on level 5 evidence, meaning expert opinion.
Similar articles
-
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.Am J Gastroenterol. 2004 Jul;99(7):1371-85. doi: 10.1111/j.1572-0241.2004.40036.x. Am J Gastroenterol. 2004. PMID: 15233681
-
Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee.Am J Gastroenterol. 1997 Feb;92(2):204-11. Am J Gastroenterol. 1997. PMID: 9040192 Review.
-
Management of primary sclerosing cholangitis.Am J Gastroenterol. 2002 Mar;97(3):528-34. doi: 10.1111/j.1572-0241.2002.05585.x. Am J Gastroenterol. 2002. PMID: 11922543 Review.
-
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.Am J Gastroenterol. 1997 Jul;92(7):1081-91. Am J Gastroenterol. 1997. PMID: 9219775 Review.
-
Management of Crohn's disease in adults.Am J Gastroenterol. 2009 Feb;104(2):465-83; quiz 464, 484. doi: 10.1038/ajg.2008.168. Epub 2009 Jan 6. Am J Gastroenterol. 2009. PMID: 19174807
Cited by
-
A comorbidity of ulcerative colitis, ankylosing spondylitis, Takayasu's arteritis and silent thyroiditis: an extensive case-based review.Ann Med Surg (Lond). 2024 Aug 22;86(11):6742-6747. doi: 10.1097/MS9.0000000000002495. eCollection 2024 Nov. Ann Med Surg (Lond). 2024. PMID: 39525733 Free PMC article.
-
Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.Int J Biol Sci. 2024 Oct 14;20(14):5608-5672. doi: 10.7150/ijbs.98107. eCollection 2024. Int J Biol Sci. 2024. PMID: 39494333 Free PMC article. Review.
-
Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis.Adv Ther. 2024 Dec;41(12):4446-4462. doi: 10.1007/s12325-024-03003-8. Epub 2024 Oct 15. Adv Ther. 2024. PMID: 39404996 Free PMC article.
-
Xuanbi Yuyang Decoction Ameliorates DSS-Induced Colitis by Inhibiting Pyroptosis via Blocking of IL-17 Pathway Activation.J Inflamm Res. 2024 Aug 5;17:5235-5249. doi: 10.2147/JIR.S472812. eCollection 2024. J Inflamm Res. 2024. PMID: 39131209 Free PMC article.
-
Investigation of Possible Positive Effects of Arbutin Application in Experimental Colitis Model.Turk J Gastroenterol. 2024 Jul;35(7):523-531. doi: 10.5152/tjg.2024.23205. Turk J Gastroenterol. 2024. PMID: 39128087 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
